Human medicines European public assessment report (EPAR): Gohibic, vilobelimab, Status: Opinion Alf Claesson 2024-11-15 UncategorizedHuman medicines European public assessment report (EPAR): Gohibic, vilobelimab, Status: OpinionRelatedNext post →